đź“‹ FDA Reference

jetstream g3 se system jetstream g3 sf system model pv31230 jetstream g3 se catheter and control pod pvcn100 pv con

Pathway Medical Technologies

Summary: The Jetstream G3 SE/SF System is a medical device used for atherectomy and mechanical thrombectomy in arterial procedures. It is primarily used by interventional cardiologists and vascular surgeons.

FDA Clearance Information

Pathway 510K
Decision Date June 11, 2010
Product Code MCW
Device Class Class 2
Evidence 18 studies

The Jetstream G3 SE/SF System was cleared by the FDA through the 510(k) pathway on June 11, 2010. It is manufactured by Pathway Medical Technologies and classified as a Class II device.

What It Is

The Jetstream G3 SE/SF System is an atherectomy device designed to remove atherosclerotic plaque and thrombus from peripheral arteries. It consists of a catheter and control pod that work together to mechanically excise and aspirate debris, improving blood flow. The system is particularly useful in treating peripheral artery disease (PAD) by restoring vessel patency.

Clinical Applications

This device is commonly used in interventional cardiology and vascular surgery settings for patients with peripheral artery disease. It is suitable for use in hospital cath labs and outpatient vascular centers. The Jetstream system is often employed in procedures to treat femoropopliteal and infrapopliteal arterial lesions, helping to alleviate symptoms such as claudication and critical limb ischemia.

Indications for Use

The Jetstream G3 SE/SF System is indicated for patients with peripheral artery disease who require removal of arterial plaque or thrombus. It is used to improve blood flow in patients with blocked or narrowed arteries, particularly in the legs.

Practical Considerations

The Jetstream system comes in various catheter sizes to accommodate different vessel diameters. It is compatible with standard guidewires and requires careful technique to ensure effective plaque removal while minimizing vessel trauma. Clinicians should be trained in its use to optimize outcomes.

Linked Studies (18)

PubMed • 2025

Jetstream Atherectomy with Paclitaxel-Coated Balloons: 3-Year Outcomes of the Prospective Randomized JET-RANGER Study.

The International journal of angiology : official publication of the International College of Angiology, Inc

RCT View Source →
PubMed • 2025

Insights From the FDA's MAUDE Database Regarding the Real-World Safety of Jetstream Atherectomy for Peripheral Arterial Disease.

Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2024

JETWING technique: Combination therapy of JETSTREAMⓇ and aggressive wire recanalization in calcified atheroma and dilatation technique for eccentric heavy calcified plaques using WINGMAN for insertion of protection wire.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions

View Source →
PubMed • 2023

Jetstream Atherectomy with Paclitaxel-Coated Balloons: Two-Year Outcome of the Prospective Randomized JET-RANGER Study.

Vascular health and risk management

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2022

Jetstream Atherectomy Followed by Paclitaxel-Coated Balloons versus Balloon Angioplasty Followed by Paclitaxel-Coated Balloons: Twelve-Month Exploratory Results of the Prospective Randomized JET-RANGER Study.

Vascular health and risk management

RCT|prospective View Source →
PubMed • 2022

Jetstream Rotational Atherectomy and Drug Coated Balloon Angioplasty with In Stent Re-stenosis and Occlusions. A Two Centre Study.

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery

View Source →
PubMed • 2021

JetStream Atherectomy for the Treatment of In-Stent Restenosis of the Femoropopliteal Segment: One-Year Results of the JET-ISR Study.

Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2021

Jetstream Atherectomy in Treating Femoropopliteal In-Stent Restenosis: Meta-Analysis of the JETSTREAM-ISR and JET-ISR Trials.

The Journal of invasive cardiology

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2020

Jetstream Atherectomy System for Treatment of Femoropopliteal Artery Disease: A Single Center Experience and Mid-term Outcomes.

Annals of vascular surgery

Other View Source →
PubMed • 2019

Jetstream Atherectomy System treatment of femoropopliteal arteries: Results of the post-market JET Registry.

Cardiovascular revascularization medicine : including molecular interventions

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2015

JETSTREAM Atherectomy: A Review of Technique, Tips, and Tricks in Treating the Femoropopliteal Lesions.

The International journal of angiology : official publication of the International College of Angiology, Inc

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2012

Successful management of lower extremity distal embolization following percutaneous atherectomy with the JetStream G3 device.

The Journal of invasive cardiology

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2009

Use and abuse of atherectomy: where should it be used?

Seminars in vascular surgery

RCT|prospective|retrospective|case Series|other View Source →
ClinicalTrials.gov

A Study to Collect Intravascular Ultrasound Images Before and After Treatment With the Jetstream System

View Source →
ClinicalTrials.gov

JetStream Atherectomy for the Treatment of In-stent Restenosis

View Source →
ClinicalTrials.gov

Jetstream in Treatment of Occlusive Atherosclerotic Lesions in the SFA and/or PPA

View Source →
ClinicalTrials.gov

The Jetstream (JET) Post-market Registry

View Source →
ClinicalTrials.gov

The Jetstream G3™ Calcium Study

View Source →

Frequently Asked Questions

What is the Jetstream G3 SE/SF System used for?

The Jetstream G3 SE/SF System is used for atherectomy and mechanical thrombectomy to remove plaque and thrombus from peripheral arteries.

What specialties typically use this device?

Interventional cardiologists and vascular surgeons typically use this device in procedures to treat peripheral artery disease.

What are the FDA-cleared indications?

The device is indicated for the removal of atherosclerotic plaque and thrombus in peripheral arteries to improve blood flow.

Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference. It does not constitute medical advice, product endorsement, or a recommendation for clinical use. Always consult manufacturer documentation and clinical judgment for patient care decisions.

📬 Stay Updated

Get the latest vascular education content delivered to your inbox.